Foscarnet sodium, with the CAS number 63585-09-1, is an antiviral medication primarily used to treat infections caused by certain viruses, particularly cytomegalovirus (CMV) in immunocompromised patients. It is a phosphonoformate compound that acts as a pyrophosphate analog, inhibiting viral DNA polymerase and thereby preventing viral replication. Foscarnet sodium is typically administered intravenously and is known for its ability to bypass the need for viral kinases, making it effective against resistant strains of viruses. The substance is characterized by its solubility in water, which facilitates its use in clinical settings. However, it can have side effects, including renal toxicity and electrolyte imbalances, necessitating careful monitoring during treatment. Foscarnet sodium is also notable for its lack of cross-resistance with other antiviral agents, providing an alternative therapeutic option for patients who do not respond to conventional treatments. Its chemical structure includes a phosphonic acid moiety, contributing to its mechanism of action and pharmacological properties.

Foscarnet sodium

63585-09-1: Phosphonoformic acid trisodium salt, A 29622, Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt, Phosphinecarboxylic acid, 1,1-dihydroxy-, 1-oxide, sodium salt (1:3), Trisodium phosphonoformate

Sodium phosphonatoformate

Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt

Foscarnet sodium (Phosphonoformate) is an antiviral agent used in the treatment of cytomegalovirus retinitis.

Foscarnet sodium is a pyrophosphate analog antiviral agent with action on viral DNA polymerase and is used for treating cytomegalovirus and herpes simplex virus infections.

CAS 63585-09-1: Foscarnet sodium

Sodium phosphonatoformate

Ref: 54-OR1028429

Foscarnet sodium

Ref: 7W-GP0052

Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt

Ref: IN-DA01DN8O

Foscarnet sodium

Ref: TM-T0220

Foscarnet sodium

Ref: 54-BUP16089

Foscarnet sodium

Ref: 3D-FF23596